Allergen (AGN) Ubrogepant Opportunity Could Be 'Significant' - Cowen
Tweet Send to a Friend
Cowen analyst Ken Cacciatore reiterated an Outperform rating and $255 price target on Allergen (NYSE: AGN) price target after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
